Flex Biomedical Receives New Funding Round

  • Feed Type
  • Date
    11/3/2010
  • Company Name
    Flex Biomedical
  • Mailing Address
    505 S. Rosa Road Madison, WI 53719
  • Company Description
    Flex Biomedical’s lead product is a synthetic polymer, the Flex Polymer, designed to treat osteoarthritis, an incurable joint disease that affects millions around the world.
  • Website
    http://www.flexbio.com/
  • Transaction Type
    Venture Equity
  • Transaction Amount
    Undisclosed
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed